In mammals, β-nicotinamide mononucleotide is generated from nicotinamide (Nam) under the catalysis of Nampt (a protease in the body), and then nicotinamide mononucleotide is converted into NAD+ under the catalysis of nicotinamide mononucleotide adenylyltransferase. Nicotinamide mononucleotide is a direct way to supplement NAD+. Precisely by significantly enhancing the ability of intracellular DNA damage repair, nicotinamide mononucleotide ultimately achieves the effect of reversing aging. Nicotinamide mononucleotide is converted into "nicotinamide adenine dinucleotide (NAD)", a substance essential for energy metabolism in the body. In mouse experiments, it has been confirmed that nicotinamide mononucleotide can activate a gene called acetylase in the body, thereby exerting effects such as prolonging lifespan and treating diabetes. NAD is a substance that the human body can originally produce, and studies have confirmed that the content of NAD in the body decreases with age.
Applications
β-nicotinamide mononucleotide is a precursor substance of NAD+, the cofactor of longevity proteins in the human body. NAD+ is an important coenzyme in the tricarboxylic acid cycle, promoting the metabolism of carbohydrates, fats, and amino acids, and participating in energy synthesis; NAD+ is also the only substrate for NAD-consuming enzymes (the only substrate for DNA repair enzyme PARP, the only substrate for longevity protein Sirtuins, and the only substrate for cyclic ADP-ribose synthase CD38/157). NAD+ is involved in all aspects of human metabolism and is a key coenzyme. Without NAD+, metabolism cannot proceed normally. Elderly people lack NAD+, so various minor and major health problems arise. By additionally supplementing NAD+, comprehensive anti-aging can be achieved. Preclinical studies have shown that NMN has various pharmacological activities in cardiac and cerebral ischemia, Alzheimer's disease, diet and age-induced type 2 diabetes, and obesity. As a precursor drug of NAD+, NMN exerts its pharmacological effects mainly by synthesizing NAD+ in the body, all of which are related to the deficiency of NAD+.
| Property | Value |
|
| Melting Point | 166 °C(dec.) |
|
| Storage Condition | -20°C |
|
| Solubility | Soluble in DMSO (slightly heated), methanol (slightly), water (slightly) |
|
| Form | Solid |
|
| Color | White to yellow |
|
| Merck | 13,6697 |
|
| BRN | 3570187 |
|
| Stability | Very hygroscopic |
|
| InChI | InChI=1/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/s3 |
|
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
|
| SMILES | O[C@@H]1C@@HO &1:1,2,3,11,r |
|